Multi-center Clinical, Radiographic, and Surgical Outcomes of Silent Tpit+ Pituitary Neuroendocrine Tumors
Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398
DOI: 10.1055/s-0044-1779922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Spencer Raub und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Current diagnosis of pituitary neuroendocrine tumors (PitNETs) is based on immunohistochemical staining of the lineage specific transcription factors T-PIT, PIT-1, and SF-1. While staining for anterior pituitary hormones is often also performed, clinical outcomes based on lineage specific transcription factors is limited due to their recent adoption within the WHO classification and lack of widespread adoption within clinical labs. Specifically, silent corticotroph (SC) PitNETs often exhibit more aggressive clinical behavior as compared to PitNETs expressing other anterior pituitary hormones. While the use of T-PIT has afforded improved diagnosis of SC PitNETs, the literature has yet to characterize the behavior and outcomes of silent TPIT+ PitNETs versus multilineage T-PIT+ tumors.
Objective
To evaluate a multicenter surgical series of silent T-PIT+ PitNETs to characterize their radiographic appearance, and clinical outcomes and compare those tumors with multi-lineage transcription factor expression.
Methods
A multi-center, multi-surgeon retrospective clinical study of 1,475 patients who underwent resection of PitNETs at the University of Washington and University of Southern California between 2011 and 2024 was performed. Tumors with immunohistochemical staining of T-PIT were identified and subsequently stratified by the absence of or co-expression of the PIT-1 and SF-1 transcription factors. Patients with Cushing’s disease were excluded. Demographic information, radiographic characteristics, and surgical outcomes were identified. Progression/recurrence was visualized using Kaplan–Meier analysis. Individual patient data were visualized using a swimmers plot.
Results
A total of 107 T-PIT+ tumors were identified and after excluding patients with Cushing’s Disease, a total of 70 patients with silent T-PIT+ PitNETs remained for study. Patients were stratified by single lineage (T-PIT+ only) versus multi-lineage (T-PIT+ ± PIT-1/SF-1). The mean follow-up was 12.3 months. The average age was 51.3 ± 14.0 years and 72.3% of patients were women. The majority of cases were of single T-PIT+ lineage (80.0%). A total of 7.1%, 2.9%, and 10.0% of cases were also positive for PIT-1, SF-1, or both PIT-1 and SF-1, respectively. Single lineage T-PIT+ tumors exhibited similar tumor size ( p = 0.09) and cavernous sinus invasion ( p = 0.07), though increased rates of suprasellar invasion ( p = 0.002) as compared to those tumors staining for multiple transcription factors in addition to T-PIT. A total of 97.1% of cases were treated via endoscopic endonasal approach. Gross total resection was achieved in a total of 67.1% of cases and was not statistically different between single and multi-lineage cases ( p = 0.203). Recurrence/progression only occurred in single lineage T-PIT+ tumors (10.7%) and is visualized in [ Figure 1 ]. Of those patients that experienced recurrence/progression, 50% underwent additional surgery, 16.7% underwent surgery and radiosurgery, and 33.3% are currently being monitored with serial imaging. A swimmers plot visualizing duration of follow-up, recurrence/progression status, and subsequent treatment is shown in [ Fig. 2 ].
Conclusion
The current WHO classification of PitNETs incorporates lineage specific transcription factors are only beginning to be widely utilized. Here, we show that single lineage T-PIT+ PitNETs have more aggressive radiographic features and a higher rate of recurrence/progression as compared to multi-lineage T-PIT+ tumors. The literature would benefit from multi-disciplinary studies to further understand this association. Fig. 1 Fig. 2 Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Raub, S., Hanks, T., Eaton, J., Tyrtova, E., Zhao, Z., III, N. G., Peterson, R., Zada, G., Emerson, S., Ferreira, M., & Ruzevick, J. (2024). Multi-center Clinical, Radiographic, and Surgical Outcomes of Silent Tpit+ Pituitary Neuroendocrine Tumors. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779922
Vancouver
Raub S, Hanks T, Eaton J, Tyrtova E, Zhao Z, III NG, et al. Multi-center Clinical, Radiographic, and Surgical Outcomes of Silent Tpit+ Pituitary Neuroendocrine Tumors. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779922
BibTeX
@article{Raub2024,
author = {Raub, Spencer and Hanks, Thomas and Eaton, Jessica and Tyrtova, Evgeniya and Zhao, Zirun and III, Norman Garrett and Peterson, Racheal and Zada, Gabriel and Emerson, Samuel and Ferreira, Manuel and Ruzevick, Jacob},
title = {Multi-center Clinical, Radiographic, and Surgical Outcomes of Silent Tpit+ Pituitary Neuroendocrine Tumors},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2024},
volume = {85},
number = {S 01 S 01},
pages = {S1--S398},
doi = {10.1055/s-0044-1779922}
}
EUVIMED